CN114689738A - Method for simultaneously detecting multiple nucleoside components in antler - Google Patents
Method for simultaneously detecting multiple nucleoside components in antler Download PDFInfo
- Publication number
- CN114689738A CN114689738A CN202210064335.4A CN202210064335A CN114689738A CN 114689738 A CN114689738 A CN 114689738A CN 202210064335 A CN202210064335 A CN 202210064335A CN 114689738 A CN114689738 A CN 114689738A
- Authority
- CN
- China
- Prior art keywords
- antler
- solution
- mobile phase
- nucleoside
- simultaneously detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003056 antler Anatomy 0.000 title claims abstract description 53
- 239000002777 nucleoside Substances 0.000 title claims abstract description 52
- 150000003833 nucleoside derivatives Chemical class 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 27
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims abstract description 38
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims abstract description 36
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims abstract description 36
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims abstract description 36
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims abstract description 36
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 claims abstract description 35
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims abstract description 34
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims abstract description 32
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229940075420 xanthine Drugs 0.000 claims abstract description 19
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 claims abstract description 18
- YKBGVTZYEHREMT-UHFFFAOYSA-N 2'-deoxyguanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(CO)O1 YKBGVTZYEHREMT-UHFFFAOYSA-N 0.000 claims abstract description 18
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims abstract description 18
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims abstract description 18
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims abstract description 18
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930010555 Inosine Natural products 0.000 claims abstract description 18
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims abstract description 18
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims abstract description 18
- 229940029575 guanosine Drugs 0.000 claims abstract description 18
- 229960003786 inosine Drugs 0.000 claims abstract description 18
- 239000000243 solution Substances 0.000 claims abstract description 18
- 229940104230 thymidine Drugs 0.000 claims abstract description 18
- 229940035893 uracil Drugs 0.000 claims abstract description 18
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims abstract description 16
- 229940113082 thymine Drugs 0.000 claims abstract description 16
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940045145 uridine Drugs 0.000 claims abstract description 16
- 239000012085 test solution Substances 0.000 claims abstract description 15
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 10
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims abstract description 10
- MXHRCPNRJAMMIM-ULQXZJNLSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidine-2,4-dione Chemical compound O=C1NC(=O)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 MXHRCPNRJAMMIM-ULQXZJNLSA-N 0.000 claims abstract description 9
- 239000012088 reference solution Substances 0.000 claims abstract description 9
- 238000005303 weighing Methods 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 239000006228 supernatant Substances 0.000 claims abstract description 6
- 238000007865 diluting Methods 0.000 claims abstract description 3
- 241000282994 Cervidae Species 0.000 claims description 33
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 11
- 125000003835 nucleoside group Chemical group 0.000 claims description 11
- 241000283011 Rangifer Species 0.000 claims description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 7
- 235000019253 formic acid Nutrition 0.000 claims description 7
- 241000282988 Capreolus Species 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 241000283007 Cervus nippon Species 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 239000012452 mother liquor Substances 0.000 claims description 3
- 241000283026 Cervus elaphus Species 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 239000010413 mother solution Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 238000002137 ultrasound extraction Methods 0.000 claims description 2
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 abstract description 9
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 238000001195 ultra high performance liquid chromatography Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 17
- 238000000605 extraction Methods 0.000 description 9
- 101150041393 rsd gene Proteins 0.000 description 8
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 7
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 241000282836 Camelus dromedarius Species 0.000 description 3
- 241000282985 Cervus Species 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 241001416181 Axis axis Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007417 hierarchical cluster analysis Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000000581 reactive spray deposition Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 241000282979 Alces alces Species 0.000 description 1
- -1 BEH Amide Chemical class 0.000 description 1
- 235000004415 Burchellia bubalina Nutrition 0.000 description 1
- 240000008537 Burchellia bubalina Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8603—Signal analysis with integration or differentiation
- G01N30/8606—Integration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N2030/042—Standards
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8603—Signal analysis with integration or differentiation
- G01N2030/862—Other mathematical operations for data preprocessing
Landscapes
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Algebra (AREA)
- Mathematical Analysis (AREA)
- Mathematical Optimization (AREA)
- Pure & Applied Mathematics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a method for simultaneously detecting multiple nucleoside components in antler, which comprises the following steps: preparing a test solution: adding water into cornu Cervi powder, shaking, mixing, refrigerating, standing, ultrasonic extracting, centrifuging, collecting supernatant, and filtering; preparation of mixed control solution: accurately weighing proper amounts of cytidine, uracil, hypoxanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine, thymidine, guanine and xanthine respectively, dissolving and diluting to prepare a mixed reference solution; detecting the content of UPLC: and carrying out ultra-high performance liquid chromatography detection on the test solution and the mixed reference solution. The detection method disclosed by the invention is simple and convenient to operate, high in sensitivity, good in stability, repeatability and precision, can be used for comprehensively analyzing nucleoside components in the antler, and provides a basis for developing and utilizing commercial antler instead of medicinal antler.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine quality detection, and particularly relates to a method for simultaneously detecting multiple nucleoside components in deer horns.
Background
Antler is one of the traditional rare Chinese medicines in China, has a long history of medication, and is recorded in Shen nong's herbal Jing. Antler recorded in ' pharmacopoeia of the people's republic of China ' in 2020 edition is ossified horn of Cervus elaphus Linnaeus or Cervus Nippon Temminck of Cervidae or horn base dropped in the spring of the second year after antler sawing, and has the effects of warming kidney yang, strengthening tendons and bones, and relieving swelling and promoting blood circulation. Modern medicine considers that the antler contains rich nutrient substances including amino acids, polypeptides, nucleosides, polysaccharides, lipids, sex hormones, mineral elements and the like, and has wide pharmacological actions of resisting fatigue, resisting osteoporosis, inhibiting hyperplasia of mammary glands, resisting viruses, protecting gastric mucosa, resisting inflammation, easing pain and the like.
Since wild red deer and sika deer are rare, artificially bred deer is mostly matted, commercial deer antler is often replaced by horn of other deer family animals, including reindeer horn, camel horn, roe deer horn, buffalo horn, etc. The antler has similar pharmacological action and chemical components with the medicinal antler, has feasibility of replacing resources with the medicinal antler, but has no scientific evaluation index in the aspect of medicine. Nucleosides are one of the main chemical components of deer antler, not only constitute the basic components of DNA and RNA, but also have various biological activities, such as anti-inflammatory, antiviral, neuroprotective, hepatoprotective, etc. Therefore, the research on the nucleoside components in different deer horns has important significance for developing medicines or health care products taking the deer horns as raw materials.
In view of the above, the invention adopts UPLC-DAD technology to measure the content of 13 nucleosides in 30 deer antler samples of 2 medicinal deer antlers and common counterfeits thereof (moose, reindeer and roe deer), and carries out quality evaluation on the deer antlers by multivariate statistical methods such as principal component analysis, hierarchical clustering analysis and the like so as to provide basis for development and utilization of medicinal deer antler substitute resources, relieve the current situation of resource shortage in the current deer antler market, guide and promote the healthy development of deer antler resource utilization and protection, and provide demonstration for research of animal medicaments.
Disclosure of Invention
The invention aims to solve the defects of the prior art and provides a method for simultaneously detecting multiple nucleoside components in antler, a device and application thereof.
The invention is implemented by the following technical scheme:
a method for simultaneously detecting multiple nucleoside components in antler comprises the following steps:
preparation of a test solution: cutting cornu Cervi into small pieces, pulverizing, and sieving to obtain cornu Cervi powder; adding distilled water into cornu Cervi powder, shaking, mixing, refrigerating, standing, ultrasonic extracting, centrifuging, collecting supernatant, and filtering to obtain test solution;
preparation of mixed control solution: accurately weighing proper amounts of cytidine, uracil, guanine, hypoxanthine, xanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine and thymidine respectively, and adding distilled water to dissolve to prepare a single reference mother solution, wherein 2mmoL/L NaOH solution is required to be added for assisting in dissolving the guanine and the xanthine; respectively taking a proper amount of each reference mother liquor, mixing, and diluting with distilled water to prepare a mixed reference solution;
detecting the content of the nucleoside by UPLC: respectively and precisely sucking 5 mu L of each prepared test solution and mixed reference solution, injecting the solutions into an ultra-high performance liquid chromatograph, and measuring to obtain the content of cytidine, uracil, hypoxanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine and thymidine.
Preferably, said deer horn is taken from elk, sika deer, roe deer, moose deer or reindeer.
Preferably, the specific preparation method of the test solution is as follows: taking 0.1g of antler powder sieved by a 40-mesh sieve, placing the antler powder into a 2mL centrifuge tube, precisely weighing, accurately adding 1mL of distilled water, uniformly mixing by oscillation, refrigerating and standing for 10-16h, and performing ultrasonic extraction at room temperature for 60min, wherein the ultrasonic frequency is 50 KHz; and (4) filtering the supernatant with a 0.45-micron microporous filter membrane to obtain a test solution.
Preferably, the addition amount of the NaOH solution is 0-200ul in the preparation process of the mixed control solution.
Preferably, the mixed control solution contains cytidine, uracil, guanine, hypoxanthine, xanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine, and thymidine in the following mass concentrations: 10.24. mu.g/mL, 10.05. mu.g/mL, 10.54. mu.g/mL, 10.07. mu.g/mL, 10.14. mu.g/mL, 10.07. mu.g/mL, 10.17. mu.g/mL, 10.11. mu.g/mL, 10.03. mu.g/mL, 10.02. mu.g/mL, 10.51. mu.g/mL, 10.01. mu.g/mL, 10.05. mu.g/mL.
Preferably, the chromatographic conditions in the step of detecting the content of the nucleosides by UPLC are: adopting an ACQUITY HSS T3100X 2.1mm, 1.7 μm chromatographic column; the column temperature is 30 ℃; the flow rate is 0.3 mL/min; the detection wavelength is 260 nm; gradient elution was performed with 0.06% formic acid aqueous solution as mobile phase a and acetonitrile as mobile phase B.
Preferably, the procedure of the gradient elution is: 0-3min, the mobile phase A is 100%, and the mobile phase B is 0%; 3-7min, changing the mobile phase A from 100% to 95% and the mobile phase B from 0% to 5%; 7-12min, changing the uniform speed of the mobile phase A from 95% to 85%, and changing the uniform speed of the mobile phase B from 5% to 15%; 12-13min, the mobile phase A is 85%, and the mobile phase B is 15%.
Compared with the prior art, the invention has the following beneficial effects: the ultrahigh performance liquid chromatography detection method can simultaneously detect the content of 13 nucleosides in deer horns, including cytidine, uracil, guanine, hypoxanthine, xanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine, and thymidine; the method is simple and convenient to operate, high in sensitivity and good in stability; the obtained chromatogram has stable baseline, good peak shape and high separation degree, can well reflect the real content of the 13 nucleosides in the sample so as to comprehensively analyze the nucleoside components of the antler, provide scientific basis for the quality control of the antler and provide reference for replacing medicinal antler with commercial antler to expand medicinal antler resources.
Drawings
FIG. 1 is a UPLC profile of 13 nucleoside mixed controls and five antler samples of the invention.
In the figure: 1. cytidine; 2. uracil; 3. guanine; 4. hypoxanthine; 5. xanthine; 6. uridine; 7. thymine; 8.2' -deoxyuridine; 9. inosine; 10. guanosine; 11.2' -deoxyinosine; 12.2' -deoxyguanosine; thymidine; A. a nucleoside control; B. a deer antler sample; C. a spotted deer horn sample; D. reindeer horn sample; E. a camel antler sample; F. roe deer horn sample; G. a blank solution.
Detailed Description
The invention is further illustrated by the following figures and examples, without however restricting the scope of the invention to these examples.
Example 1
1.1 optimization of the extraction Process
Preliminary experiments were carried out on the extraction solvent (pure water, 10% methanol, 20% methanol) and extraction time (60min, 120min) of the nucleoside components in deer antlers. The test solutions obtained by using different extraction methods were analyzed under the same chromatographic conditions, and the results showed that: the method comprises the following steps of (1) extracting a sample solution by pure water to obtain a sample solution, wherein the sample solution contains most nucleoside components, and has a better peak shape and a larger peak area; the results of the measurement of the extraction time of 60min and the measurement of 120min are basically the same, and even the content of the extraction time of 120min is lower; the acetonitrile precipitation method is adopted to remove protein in the aqueous extract of antler, and the result shows that the content of nucleoside ingredients is reduced probably due to the protein removal operation. Therefore, the extraction efficiency is comprehensively considered, the final extraction process is determined to be pure water extraction, the extraction time is 60min, and protein is not removed.
1.2 examination of chromatographic conditions
When the content of nucleoside components in antler is measured, an acquisition UPLC HSS T3 chromatographic column, an acquisition UPLC BEH Amide chromatographic column and an acquisition UPLC BEH C18 chromatographic column are selected from the chromatographic columns for preliminary experiments. The experimental results show that: the obtained chromatogram column has poor peak shape, and the obtained chromatogram column HSS T3 has better water phase resistance and better separation effect on nucleoside components than the obtained chromatogram column BEH C18. The mobile phase selects aqueous formic acid solution-acetonitrile, the proportion of formic acid and water is continuously adjusted, the separation conditions of 13 nucleosides under different proportions are compared, and finally aqueous formic acid solution-acetonitrile with the concentration of 0.06 percent is selected as the mobile phase. As the nucleoside components have ultraviolet absorption, the ultraviolet detection of the 13 nucleoside reference substances shows that the maximum absorption wavelength of the 13 components is near 260nm, so the detection wavelength is selected to be 260 nm.
1.3 methodological investigation of the detection of Deerhorn nucleoside Components by UPLC
1.3.1 instruments and reagents
A Ultimate 3000RSLC ultra high performance liquid chromatograph equipped with a DAD detector (seimer feishell science and technology ltd); electronic balances of BSA224S type (d 0.1mg) and BP211D type (d 0.01mg) were both manufactured by sedolis scientific instruments ltd, beijing; KQ5200E ultrasonic cleaner (kunshan ultrasonic instruments ltd); TG16-WS model desk-top high-speed centrifuge (Hunan instruments laboratory development, Hunan).
Uracil (BG16a045), guanine (BK19a006), hypoxanthine (BE30a110), xanthine (CJ08B108), uridine (G23a0097), thymine (CD16B125), inosine (CJ09B206), guanosine (CJ08B112), thymidine (BG16a097) are produced by kypt biotechnology limited, cytidine (DDYJ1014-32), 2 ' -deoxyguanosine (DDYJ1014-34), 2 ' -deoxyuridine (DDYJ1014-35), 2 ' -deoxyinosine (DDYJ1014-36) are provided by medall-while-era medical technology limited, and all controls have a purity greater than 98%. Acetonitrile was chromatographically pure, produced by Sigma-aldrich. Formic acid is chromatographically pure and is produced by metropolis chemical company Limited. Ultrapure water was prepared by a Milli-Q system (Millipore, USA).
30 deer horn samples are collected in places such as Jilin Changchun, Heilongjiang peony river and the like, and are derived from five varieties of ML (red deer), MHL (spotted deer), PZ (roe deer), TL (camel deer) and XL (reindeer) according to character identification of professor of Longfei assistant and graduator of Chengjiang university of Chinese medicine and university of Chengdu, wherein the 30 deer horn samples are respectively numbered as ML1-6, MHL1-6, PZ1-6, TL1-6 and XL 1-6.
1.3.2 methods and results
(1) Preparation of Mixed control solutions
Precisely weighing appropriate amount of each reference substance, placing in a 25mL volumetric flask, and dissolving with distilled water to obtain reference substance mother liquor, wherein appropriate amount of 2mmoL/L NaOH solution is added for guanine and xanthine. Then, an appropriate amount of each control solution is diluted with distilled water to obtain a mixed control solution containing 10.24 μ g/mL of cytidine, 10.05 μ g/mL of uracil, 10.54 μ g/mL of guanine, 10.07 μ g/mL of hypoxanthine, 10.14 μ g/mL of xanthine, 10.07 μ g/mL of uridine, 10.17 μ g/mL of thymine, 10.11 μ g/mL of 2 ' -deoxyuridine, 10.03 μ g/mL of inosine, 10.02 μ g/mL of guanosine, 10.51 μ g/mL of 2 ' -deoxyinosine, 10.01 μ g/mL of 2 ' -deoxyguanosine, and 10.05 μ g/mL of thymidine.
(2) Preparation of test solution
All antler samples are cut into small pieces by an electric saw, crushed and sieved by a 40-mesh sieve for later use. Weighing cornu Cervi powder about 0.10g, precisely weighing, adding 1mL distilled water into 2mL centrifuge tube, shaking, mixing, refrigerating, standing overnight, ultrasonic extracting at room temperature (50KHz) for 60min, centrifuging, and filtering the supernatant with 0.45 μm microporous membrane.
(3) Chromatographic conditions
The column was ACQUITYHSST3 (100X 2.1mm, 1.7 μm, Waters); column temperature: 30 ℃; flow rate: 0.3 mL/min; sample injection amount: 5 μ L. Detection wavelength of 260nm, mobile phase: aqueous formic acid (a) -acetonitrile (B) at a concentration of 0.06%, gradient elution: 0-3min, 0% B; 3-7min, 0% -5% B; 7-12min, 5% -15% B; 12-13min, 15% B. Under this chromatographic condition, chromatographic peaks of 13 nucleosides were well separated. The results are shown in FIG. 1.
(4) Investigation of Linear relationships
Sucking up the mixed control solution under the item (1),adding water to dilute into a series of control solutions with different concentrations, and injecting sample for analysis according to the chromatographic conditions under the item (3). And (3) performing linear regression on the concentration (X, mu g/mL) by using the peak area (Y), calculating a regression equation and a correlation coefficient, and determining the detection limit and the quantification limit when the reference solution is diluted until the signal-to-noise ratio obtained by detection is about 3: 1 and 10: 1. The results of the linear relationship and the detection and quantification limits, see table 1, show that: the 13 nucleoside components show better linear relation (r) in the measurement range2>0.9990) with detection and quantitation limits both within the feasible range.
TABLE 113 regression equation, detection limits, quantitation limits for nucleoside components
(5) Precision survey
A control solution (0.5. mu.g/mL) was sampled continuously for 6 needles, and the peak area of each component was measured and the RSD value was calculated to evaluate the precision. The RSD of the peak area of each nucleoside was 0.38% (cytidine), 0.22% (uracil), 0.77% (guanine), 1.15% (hypoxanthine), 1.07% (xanthine), 0.45% (uridine), 2.49% (thymine), 0.74% (2 ' -deoxyuridine), 0.48% (inosine), 0.42% (guanosine), 4.23% (2 ' -deoxyinosine), 0.68% (2 ' -deoxyguanosine), 0.66% (thymidine), respectively. Indicating that the precision of the instrument is good.
(6) Repeatability survey
Precisely weighing 6 parts of antler powder of the same batch, preparing a sample solution in parallel according to the method under the item (2), injecting sample under the chromatographic condition under the item (3), and evaluating the repeatability of the method according to the RSD value of each component content in the sample. RSDs for each nucleoside content were 2.08% (cytidine), 1.02% (uracil), 3.05% (guanine), 0.80% (hypoxanthine), 1.38% (xanthine), 1.18% (uridine), 4.73% (thymine), 2.99% (2 ' -deoxyuridine), 2.28% (inosine), 1.87% (guanosine), 1.52% (2 ' -deoxyinosine), 1.28% (2 ' -deoxyguanosine), and 1.09% (thymidine, respectively. The results show that: the method has good repeatability.
(7) Stability survey
Sampling the same sample solution for 0, 3, 6, 9, 12 and 24h respectively according to the chromatographic conditions under the item (3), and calculating the RSD value of the peak area of each component to evaluate the stability of the sample. The RSD of each nucleoside peak area was 3.78% (cytidine), 3.27% (uracil), 2.19% (guanine), 1.55% (hypoxanthine), 0.73% (xanthine), 2.25% (uridine), 4.33% (thymine), 3.52% (2 ' -deoxyuridine), 1.06% (inosine), 0.37% (guanosine), 2.58% (2 ' -deoxyinosine), 2.89% (2 ' -deoxyguanosine), 1.24% (thymidine), respectively. The results show that: the stability of the tested sample is good.
(8) Investigation of sample recovery
The same batch of deer antler samples of known content were taken and added to the control at 80%, 100% and 120%, respectively, in triplicate. The preparation was carried out according to the method under item "(2)", and then the measurement was carried out under the chromatographic conditions under item "(3)", and the sample recovery rate and the RSD value were calculated to verify the accuracy of the method. As a result: the average sample recovery of each nucleoside was 106.49% (cytidine), 100.77% (uracil), 99.48% (guanine), 94.19% (hypoxanthine), 86.25% (xanthine), 101.93% (uridine), 91.17% (thymine), 100.48% (2 ' -deoxyuridine), 101.71% (inosine), 92.05% (guanosine), 90.62% (2 ' -deoxyinosine), 100.43% (2 ' -deoxyguanosine), and 100.99% (thymidine). RSDs are 1.35% (cytidine), 0.79% (uracil), 2.20% (guanine), 0.82% (hypoxanthine), 3.20% (xanthine), 0.56% (uridine), 2.09% (thymine), 0.46% (2 ' -deoxyuridine), 0.96% (inosine), 1.27% (guanosine), 1.03% (2 ' -deoxyinosine), 1.32% (2 ' -deoxyguanosine), 0.52% (thymidine), respectively. Shows that: the method can well reflect the real content of the 13 nucleosides in the sample.
(9) Content measurement of 30 deer horn samples
Taking 30 batches of antler medicinal material samples, preparing a test solution according to the method under the item (2), recording peak areas, and calculating the content of each component. Each batch of medicinal materials is subjected to parallel measurement twice, and the average value is calculated to be used as the content of nucleoside in the medicinal material sample, and the result is shown in the following table 2. The analysis finds that: the reindeer of five deer horn species has the highest total nucleoside content of 87.53-180.50 mug/g, and the red deer and the moose have 44.58-141.18 mug/g and 38.78-156.37 mug/g respectively. Xanthine, cytidine, uracil and hypoxanthine are main nucleoside components in deer horns, the average content of xanthine in five varieties of deer horns is the highest (25.14-44.34 mu g/g), and cytidine, uracil and hypoxanthine are arranged in the second place; the contents of the four nucleosides in the reindeer horn are equivalent to or even superior to those of the medicinal deer horn. The different components in different varieties of deer antler are inosine, guanosine, 2 ' -deoxyguanosine and thymidine, and the average relative content of inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine and thymidine is lower. Thus, the nucleoside components of the five varieties of deer antlers are not clearly distinguished at the overall nucleoside level.
Further, the main component analysis, the hierarchical clustering analysis and the orthogonal partial least square discriminant analysis find that: taking nucleoside components as evaluation indexes, the domesticated antler and the medicinal antler have chemical equivalence and can be used as potential medicinal antler resources.
TABLE 230 nucleoside content in batch samples (. mu.g/g) (n ═ 2)
Measurement result below limit of quantitation
Claims (7)
1. A method for simultaneously detecting multiple nucleoside components in antler is characterized in that: the method comprises the following steps:
preparation of a test solution: cutting cornu Cervi into small pieces, pulverizing, and sieving to obtain cornu Cervi powder; adding distilled water into cornu Cervi powder, shaking, mixing, refrigerating, standing, ultrasonic extracting, centrifuging, collecting supernatant, and filtering to obtain test solution;
preparation of mixed control solution: accurately weighing proper amounts of cytidine, uracil, guanine, hypoxanthine, xanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine and thymidine respectively, and adding distilled water to dissolve to prepare a single reference mother solution, wherein 2mmoL/L NaOH solution is required to be added for assisting in dissolving the guanine and the xanthine; respectively taking a proper amount of each reference mother liquor, mixing, and diluting with distilled water to prepare a mixed reference solution;
detecting the content of the nucleoside by UPLC: precisely absorbing 5 mu L of each of the test solution and the mixed reference solution, injecting the solution into an ultra-high performance liquid chromatograph, and measuring to obtain the content of cytidine, uracil, hypoxanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine and thymidine.
2. The method for simultaneously detecting multiple nucleoside ingredients in antler according to claim 1, wherein: the cornu Cervi is selected from Cervus elaphus Linnaeus, Cervus nippon Temminck, roe deer, moose deer or reindeer.
3. The method for simultaneously detecting multiple nucleoside components in antler according to claim 1, characterized in that: the specific preparation method of the test solution comprises the following steps: taking 0.1g of antler powder sieved by a 40-mesh sieve, placing in a 2mL centrifuge tube, precisely weighing, accurately adding 1mL of distilled water, oscillating, mixing uniformly, refrigerating and standing for 10-16h, performing ultrasonic extraction at room temperature for 60min, wherein the ultrasonic frequency is 50 KHz; and (4) filtering the supernatant with a 0.45-micron microporous filter membrane to obtain a test solution.
4. The method for simultaneously detecting multiple nucleoside ingredients in antler according to claim 1, wherein: in the preparation process of the mixed reference solution, the addition amount of the NaOH solution is 0-200 ul.
5. The method for simultaneously detecting multiple nucleoside ingredients in antler according to claim 1, wherein: the mixed reference solution contains cytidine, uracil, guanine, hypoxanthine, xanthine, uridine, thymine, 2 ' -deoxyuridine, inosine, guanosine, 2 ' -deoxyinosine, 2 ' -deoxyguanosine, and thymidine in the mass concentrations respectively as follows: 10.24. mu.g/mL, 10.05. mu.g/mL, 10.54. mu.g/mL, 10.07. mu.g/mL, 10.14. mu.g/mL, 10.07. mu.g/mL, 10.17. mu.g/mL, 10.11. mu.g/mL, 10.03. mu.g/mL, 10.02. mu.g/mL, 10.51. mu.g/mL, 10.01. mu.g/mL, 10.05. mu.g/mL.
6. The method for simultaneously detecting multiple nucleoside ingredients in antler according to claim 1, wherein: the chromatographic conditions in the step of detecting the content of the nucleosides by UPLC are as follows: using an ACQUITY HSS T3100 × 2.1mm, 1.7 μm chromatographic column; the column temperature is 30 ℃; the flow rate is 0.3 mL/min; the detection wavelength is 260 nm; gradient elution was carried out using 0.06% formic acid aqueous solution as mobile phase a and acetonitrile as mobile phase B.
7. The method for simultaneously detecting multiple nucleoside ingredients in antler according to claim 5, wherein: the procedure for the gradient elution was: 0-3min, the mobile phase A is 100%, and the mobile phase B is 0%; 3-7min, changing the mobile phase A from 100% to 95% and the mobile phase B from 0% to 5%; 7-12min, changing the uniform speed of the mobile phase A from 95% to 85%, and changing the uniform speed of the mobile phase B from 5% to 15%; 12-13min, the mobile phase A is 85%, and the mobile phase B is 15%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210064335.4A CN114689738A (en) | 2022-01-20 | 2022-01-20 | Method for simultaneously detecting multiple nucleoside components in antler |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210064335.4A CN114689738A (en) | 2022-01-20 | 2022-01-20 | Method for simultaneously detecting multiple nucleoside components in antler |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114689738A true CN114689738A (en) | 2022-07-01 |
Family
ID=82137555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210064335.4A Pending CN114689738A (en) | 2022-01-20 | 2022-01-20 | Method for simultaneously detecting multiple nucleoside components in antler |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114689738A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115980213A (en) * | 2022-12-20 | 2023-04-18 | 天地恒一制药股份有限公司 | Construction method and application of HPLC (high Performance liquid chromatography) characteristic spectrum of ootheca Mantidis medicinal material, decoction pieces, standard decoction, dry extract powder or formula granules |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104502511A (en) * | 2015-01-04 | 2015-04-08 | 西南民族大学 | Detection method for four nucleoside ingredients in allium wallichii kunth |
CN104515817A (en) * | 2014-11-17 | 2015-04-15 | 上海征泰饲料有限公司 | Method for evaluating destroy degree on nucleotide of determination method and production technology of free nucleic acid hydrolysate in protein product |
CN108037220A (en) * | 2018-01-26 | 2018-05-15 | 上海上药第生化药业有限公司 | A kind of separation method of nucleosides and alkali radical species and its application |
CN108333289A (en) * | 2018-02-07 | 2018-07-27 | 吉林师范大学 | A kind of method of multi-analyte immunoassay control grub content |
CN109971868A (en) * | 2019-05-07 | 2019-07-05 | 镇江市食品药品监督检验中心 | One group for identifying the specific primer and deer horn authenticity identification method of deer horn |
-
2022
- 2022-01-20 CN CN202210064335.4A patent/CN114689738A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104515817A (en) * | 2014-11-17 | 2015-04-15 | 上海征泰饲料有限公司 | Method for evaluating destroy degree on nucleotide of determination method and production technology of free nucleic acid hydrolysate in protein product |
CN104502511A (en) * | 2015-01-04 | 2015-04-08 | 西南民族大学 | Detection method for four nucleoside ingredients in allium wallichii kunth |
CN108037220A (en) * | 2018-01-26 | 2018-05-15 | 上海上药第生化药业有限公司 | A kind of separation method of nucleosides and alkali radical species and its application |
CN108333289A (en) * | 2018-02-07 | 2018-07-27 | 吉林师范大学 | A kind of method of multi-analyte immunoassay control grub content |
CN109971868A (en) * | 2019-05-07 | 2019-07-05 | 镇江市食品药品监督检验中心 | One group for identifying the specific primer and deer horn authenticity identification method of deer horn |
Non-Patent Citations (2)
Title |
---|
FENGTAO LI等: "Comparative analysis of nucleosides and nucleobases from different sections of Elaphuri Davidiani Cornu and Cervi Cornu by UHPLC-MS/MS", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 83, 25 April 2013 (2013-04-25), pages 2 * |
孙印石等: "UPLC法测定不同加工方式梅花鹿鹿茸中的核苷类成分", 中草药, vol. 49, no. 4, 28 February 2018 (2018-02-28), pages 1 - 2 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115980213A (en) * | 2022-12-20 | 2023-04-18 | 天地恒一制药股份有限公司 | Construction method and application of HPLC (high Performance liquid chromatography) characteristic spectrum of ootheca Mantidis medicinal material, decoction pieces, standard decoction, dry extract powder or formula granules |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110836944A (en) | HPLC fingerprint spectrum establishment method for pediatric exterior syndrome relieving granules | |
CN107144661A (en) | It is a kind of at the same obtain Honeysuckle flower in material composition and total antioxidant activity detection method | |
CN105628834B (en) | Anaesthetic Radix Rhapontici seu Radix Echinopsis spends fingerprint and quality evaluating method | |
CN108362809B (en) | Quality evaluation method of ginkgo leaf and extract and preparation thereof | |
CN114689738A (en) | Method for simultaneously detecting multiple nucleoside components in antler | |
CN110927311B (en) | Construction method of UPLC (ultra performance liquid chromatography) characteristic spectrum of dogbane leaf medicinal material and method for measuring content of flavonoid component of dogbane leaf medicinal material | |
CN111487344A (en) | Method for detecting fingerprint spectrum of motherwort particles | |
CN111487347A (en) | Method for detecting fingerprint of Zhishu granules | |
CN115060822A (en) | Fingerprint spectrum quantitative analysis method based on Chinese medicine imprinting template component cluster | |
CN110638990B (en) | Extraction process of cassia twig, peony and rhizoma anemarrhenae prescription preparation extract | |
CN110243969B (en) | HPLC method for simultaneously determining 7 organic acids in Arisaema tuber | |
CN110243986B (en) | Blood-activating and goiter-eliminating tablet HPLC fingerprint and preparation method thereof | |
CN111505139A (en) | Method for determining content of kaempferol-3-O-rutinoside in radix tetrastigme medicinal material | |
CN112345655A (en) | Establishing method of wasp venom fingerprint, wasp venom fingerprint and application of wasp venom fingerprint | |
CN108828098B (en) | Method for determining melatonin in cotton by high performance liquid chromatography-mass spectrometry | |
CN103940918A (en) | A method of simultaneously detecting the content of artesunate and the content of dihydroartemisinin in animal blood plasma | |
CN113759037B (en) | Characteristic spectrum of formula granules of semen lepidii and/or semen lepidii as well as construction method and identification method thereof | |
CN115406997A (en) | Folium artemisiae argyi quality detection method based on HPLC fingerprint | |
CN105699581A (en) | Construction method of UPLC fingerprint of sweet clover medicinal material and standard fingerprint thereof | |
CN106153792B (en) | Fingerprint spectrum of cortex periplocae and quality detection method thereof | |
CN108490095B (en) | method for measuring contents of multiple components in gerbera piloselloides medicinal material | |
CN107894466B (en) | Determination method of HPLC fingerprint of Jinsangqi antitoxic preparation and quality control method of Jinsangqi antitoxic preparation | |
Xiong et al. | Chromatographic fingerprint analysis of Macrothelypteris torresiana and simultaneous determination of several main constituents by LC | |
CN115078588B (en) | Aspongopus and quality evaluation method of processed product thereof | |
CN117007733B (en) | High performance liquid chromatography determination method for five components in sweet wormwood herb paste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |